Non-communicable diseases account for 62 percent of deaths in India, say experts

KOCHI: Non-communicable diseases (NCDs) and injuries together have overtaken infectious and childhood diseases in terms of disease burden in every state of the country, said health experts who were attending a two-day international public health conference at the Amrita Institute of Medical Sciences on Friday.

NCDs account for 62% of all deaths in India, followed by communicable diseases (28%) and injuries (11%). While infectious and associated diseases made up majority of disease burden in most of the Indian states in 1990, this was less than half in all states in 2016.

“India’s public health situation is problematic, with underfunded and overcrowded hospitals and inadequate rural coverage. This is despite increasing demand due to the growing incidence of age and lifestyle- related chronic diseases,” said Dr Vijaykumar, chief of public health and community medicine, Amrita Hospital. The Indian healthcare sector today witnesses 50% spending on inpatient beds only for lifestyle diseases. This has resulted in the rapid development of super-specialty hospitals to combat lifestyle diseases.

Health secretary Rajeev Sadanandan said that there was an immediate need to strengthen the primary health centres (PHCs).

  • Related Posts

    Glenmark Pharma’s US arm launches Latanoprost’s bioequivalent solution

    Glenmark Pharmaceuticals said that US-based Glenmark Pharmaceuticals Inc. has launched Latanoprost Ophthalmic Solution. The aforementioned solution is bioequivalent and therapeutically equivalent to the reference listed drug Xalatan Ophthalmic Solution of…

    HC denies bail to pharma company owner for manufacturing spurious drugs

    Shimla:  The Himachal Pradesh high court on Monday declined bail to the owner of pharmaceutical company M/s Glenmars Healthcare in the Baddi area of Solan district, from where a huge…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    10, 000 Km is just a Number for Intercontinental Tele Surgery by SSIMantra

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    DGFT Extends Deadline on Application for Export of Pharma Grade Sugar

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra

    Bihar Healthcare is poised to be embraced by Robotic Surgery Mantra